Project Grant R01AG085712
Award Date
8/1/24
Completion Date
7/31/29
Dollars Obligated
$737K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
This federal Project Grant award from the National Institute on Aging (under CFDA 93.866 - Aging Research) provides $134,000 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a pilot study on a digital cognitive behavioral therapy for insomnia (DCBT-I) intervention for older adults undergoing elective orthopedic surgery.
The key objectives are to establish the feasibility of the DCBT-I protocol in this patient population and examine its effects...
This Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) provides $636,957 to Mayo Clinic to conduct a 5-year clinical trial investigating the effects of prescription opioids on brain structure and cognition in older adults with chronic pain. The primary objective is to determine if exposure to opioids is associated with changes in white matter integrity and global cognitive function. The study will randomize 200 participants with chronic osteoarthritis pain...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $238,500 to the University of Pittsburgh to conduct a randomized, blinded clinical trial evaluating the opioid-sparing effects of a telemedicine-delivered digital cognitive behavioral intervention (DCBI) for patients undergoing total knee and hip arthroplasty surgeries. The key objectives are to: 1) quantify the opioid-reducing properties of the...
This $676,000 federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to study the impact of the 2016 CDC opioid prescribing guidelines on disparities in opioid utilization among older adults with opioid-responsive pain conditions.
The research will focus on three subgroups of older adults at high risk of pain undertreatment: those with Alzheimer's and related dementias, racial/ethnic minoritized individuals, and those experiencing socioeconomic...
This federal Project Grant award from the National Institutes of Health (CFDA 93.279 - Drug Abuse and Addiction Research Programs) provides $1,105,489 to The Leland Stanford Junior University (Stanford University) to fund research aimed at reducing the risk of persistent postoperative opioid use and opioid use disorder among older adults undergoing inpatient surgery.
The key products and services to be delivered under this 2-year grant include:
Augmenting an existing dataset that links...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development, refinement, and preliminary testing of a novel, integrated Cognitive Behavioral Therapy for Insomnia and Opioid Use Disorder (CBT-IO) intervention. The $232,875 award will support tailoring the CBT-I content and delivery to the biopsychosocial needs of adults with comorbid insomnia and opioid use disorder (OUD) receiving...
This $779,969 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to improve perioperative care for patients with opioid use disorder. The grant will fund a multi-year study led by the Regents of the University of Michigan to prospectively capture patient-reported pain and opioid use among individuals with opioid use disorder undergoing common surgical procedures. The research team will also develop and...
This Project Grant award, funded by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and evaluation of a novel non-invasive, non-pharmacological device called Neurocuple for managing postoperative pain in patients undergoing total knee arthroplasty (TKA) surgery.
The $416,443 award to NCAP Medical, LLC, a for-profit manufacturer based in Heber City, Utah, will fund a randomized, placebo-controlled clinical trial to...
The National Institute on Drug Abuse (NIDA) awarded a $701,959 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Regents of the University of Michigan to improve perioperative care for patients with opioid tolerance. The project aims to prospectively capture patient-reported opioid use and pain outcomes among individuals with opioid tolerance undergoing common surgical procedures, and develop a clinical care pathway to optimize outcomes across a network of...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Northwestern University provides $684,924 to fund research examining the relationship between noradrenergic dysregulation, sleep quality, and cognitive function in older adults with insomnia. The 5-year project aims to systematically characterize central and peripheral measures of the noradrenergic system and assess their association with sleep quality and cognitive performance in insomnia patients...